Compare NLOP & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NLOP | QTRX |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.7M | 160.0M |
| IPO Year | 2022 | 2017 |
| Metric | NLOP | QTRX |
|---|---|---|
| Price | $11.26 | $3.50 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 110.2K | ★ 1.1M |
| Earning Date | 05-19-2026 | 05-06-2026 |
| Dividend Yield | ★ 52.20% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.69 | N/A |
| Revenue | ★ $118,915,000.00 | $37,632,000.00 |
| Revenue This Year | N/A | $25.49 |
| Revenue Next Year | N/A | $10.04 |
| P/E Ratio | $6.78 | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $11.24 | $2.40 |
| 52 Week High | $34.53 | $8.77 |
| Indicator | NLOP | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 32.08 | 56.95 |
| Support Level | N/A | $3.11 |
| Resistance Level | $12.26 | $3.81 |
| Average True Range (ATR) | 0.30 | 0.35 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 12.23 | 53.75 |
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns, operates, and finances a diversified portfolio of office properties mainly leased to corporate tenants on a single-tenant, net-lease basis. The company operates as a single operating and reportable segment focused on owning and managing office properties that generate revenue mainly from long-term lease agreements with tenants.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.